北美血糖监测设备市场预测至 2030 年 - 区域分析 - 按类型（连续血糖监测设备和自我血糖监测设备）、应用（1 型糖尿病和 2 型糖尿病）、测试类型（指尖测试和备用站点测试）、和最终用户（医疗保健设置和自我/家庭护理）
No. of Pages: 99 | Report Code: BMIRE00029122 | Category: Life Sciences
No. of Pages: 99 | Report Code: BMIRE00029122 | Category: Life Sciences
北美血糖监测设备市场预计将从 2022 年的 59.8778 亿美元增长到 2030 年的 144.0958 亿美元。预计从 2022 年到 2022 年将以 11.6% 的复合年增长率增长2030年。
血糖监测设备的快速技术进步推动北美血糖监测设备市场
北美血糖监测设备市场概述< /strong>
北美血糖监测设备市场已细分为美国、加拿大和墨西哥。该地区的市场增长归因于糖尿病患病率的上升，而老年人口的增加是积极影响市场增长的主要因素。此外，监测设备的技术进步进一步促进了 2022-2030 年的整体市场增长。
北美血糖监测设备市场收入和 2030 年预测（百万美元） )
北美血糖监测设备市场细分
北美血糖监测设备市场按类型、应用、测试地点、最终用户和国家/地区进行细分。
根据类型，北美血糖监测设备市场进行细分分为连续血糖监测装置和自我血糖监测装置。 2022 年，自我血糖监测设备细分市场在北美血糖监测设备市场中占据较大份额。
根据应用情况，北美地区血糖监测设备市场分为1型糖尿病和2型糖尿病。 2022年，2型糖尿病细分市场在北美血糖监测设备市场中占据较大份额。
根据测试站点，北美血糖监测设备市场细分为指尖测试和备用站点测试。 2022 年，指尖测试细分市场在北美血糖监测设备市场中占据较大份额。
根据最终用户，北美血糖监测设备市场细分为医疗保健环境和自我/家庭护理。 2022 年，自我/家庭护理细分市场在北美血糖监测设备市场中占据较大份额。
根据国家/地区，北美血糖监测设备市场细分为美国、加拿大和墨西哥。 2022 年，美国将主导北美血糖监测设备市场。
B. Braun SE、F. Hoffmann-La Roche Ltd、LifeScan Inc 、Medtronic Plc、Abbott Laboratories、Ypsomed Holding AG、Senseonics Holdings Inc、Nipro Corp、GE HealthCare Technologies Inc 和 Terumo Corp 是北美血糖监测设备市场的一些领先公司。< /p>
Strategic insights for North America Glucose Monitoring Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 5,987.78 Million |
| Market Size by 2030 | US$ 14,409.58 Million |
| Global CAGR (2022 - 2030) | 11.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Glucose Monitoring Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Glucose Monitoring Devices Market is valued at US$ 5,987.78 Million in 2022, it is projected to reach US$ 14,409.58 Million by 2030.
As per our report North America Glucose Monitoring Devices Market, the market size is valued at US$ 5,987.78 Million in 2022, projecting it to reach US$ 14,409.58 Million by 2030. This translates to a CAGR of approximately 11.6% during the forecast period.
The North America Glucose Monitoring Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Glucose Monitoring Devices Market report:
The North America Glucose Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Glucose Monitoring Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Glucose Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Glucose Monitoring Devices Market
